CEL-SCI Corp (CVM)
1.63
+0.15
(+10.14%)
USD |
NYAM |
May 03, 16:00
1.64
+0.01
(+0.61%)
After-Hours: 20:00
CEL-SCI Free Cash Flow: -23.45M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.45M |
| September 30, 2023 | -23.22M |
| June 30, 2023 | -23.10M |
| March 31, 2023 | -23.09M |
| December 31, 2022 | -18.78M |
| September 30, 2022 | -18.90M |
| June 30, 2022 | -19.18M |
| March 31, 2022 | -20.52M |
| December 31, 2021 | -25.69M |
| September 30, 2021 | -27.83M |
| June 30, 2021 | -27.32M |
| March 31, 2021 | -24.63M |
| December 31, 2020 | -20.73M |
| September 30, 2020 | -17.97M |
| June 30, 2020 | -17.20M |
| March 31, 2020 | -17.39M |
| December 31, 2019 | -16.64M |
| September 30, 2019 | -16.66M |
| June 30, 2019 | -17.02M |
| March 31, 2019 | -15.10M |
| December 31, 2018 | -15.06M |
| September 30, 2018 | -13.45M |
| June 30, 2018 | -12.60M |
| March 31, 2018 | -12.94M |
| December 31, 2017 | -12.18M |
| Date | Value |
|---|---|
| September 30, 2017 | -13.81M |
| June 30, 2017 | -17.22M |
| March 31, 2017 | -19.53M |
| December 31, 2016 | -21.50M |
| September 30, 2016 | -23.12M |
| June 30, 2016 | -21.63M |
| March 31, 2016 | -22.45M |
| December 31, 2015 | -24.32M |
| September 30, 2015 | -23.93M |
| June 30, 2015 | -24.33M |
| March 31, 2015 | -24.14M |
| December 31, 2014 | -22.60M |
| September 30, 2014 | -23.07M |
| June 30, 2014 | -20.72M |
| March 31, 2014 | -18.15M |
| December 31, 2013 | -16.60M |
| September 30, 2013 | -13.68M |
| June 30, 2013 | -13.54M |
| March 31, 2013 | -13.21M |
| December 31, 2012 | -12.71M |
| September 30, 2012 | -12.32M |
| June 30, 2012 | -13.99M |
| March 31, 2012 | -18.08M |
| December 31, 2011 | -19.06M |
| September 30, 2011 | -22.89M |
Free Cash Flow Range, Past 5 Years
-27.83M
Minimum
Sep 2021
-16.64M
Maximum
Dec 2019
-21.02M
Average
-20.52M
Median
Mar 2022
Free Cash Flow Benchmarks
| Synlogic Inc | -51.83M |
| BioXcel Therapeutics Inc | -155.03M |
| IGM Biosciences Inc | -204.61M |
| Intelligent Bio Solutions Inc | -7.341M |
| Syra Health Corp | -2.774M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.888M |
| Cash from Investing (Quarterly) | -0.0649M |
| Cash from Financing (Quarterly) | 4.048M |
| Free Cash Flow Per Share (Quarterly) | -0.1022 |
| Free Cash Flow Yield | -31.46% |